Hutch News

Hutch News

Stories tagged 'cancer immunotherapy trials network'

On immunotherapy trial, long-term survivors of deadly skin cancer point to a hopeful future

Once unheard-of survival rates seen among patients with advanced Merkel cell carcinoma

Feb. 6, 2019 | By Susan Keown / Fred Hutch News Service

More than two-thirds of people with advanced Merkel cell carcinoma are on track to survive at least two years after starting an immunotherapy drug on a landmark trial.

View story >


Meet Global Oncology's deputy program head

Key early experiences shaped Dr. Thomas Uldrick's path toward HIV-associated cancers, global health

Feb. 22, 2018 | By Mary Engel / Fred Hutch News Service

Dr. Thomas Uldrick brings expertise in HIV-related cancers and experience in — and a passion for — developing clinical trials to his new position at Fred Hutch Global Oncology.

View story >


For cancer patients with HIV, immunotherapy appears safe

Checkpoint inhibitor study suggests new treatment options for patients long excluded from cancer immunotherapy clinical trials

Nov. 7, 2017 | By Mary Engel / Fred Hutch News Service

Checkpoint inhibitor study suggests new treatment options for patients long excluded from cancer immunotherapy clinical trials.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.